Where are the gaps in asthma research? A counter-perspective

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 2, 2003, Pages 244-247

  Holtzman, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; ASTHMA; ATOPY; CELL ACTIVATION; EFFECTOR CELL; EXPERIMENTAL MODEL; GENE ACTIVATION; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE GENE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; MEDICAL RESEARCH; NONHUMAN; PARENCHYMA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; REVIEW; RNA STABILITY; RNA VIRUS INFECTION; TH2 CELL; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0037329455     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.141     Document Type: Review

References (25)

1. Kay AB. Allergy and allergic diseases. New Engl J Med 2001;344:30-7.
2. Busse WW, Lemanske RFJ. Asthma. New Engl J Med 2001;344:350-62.
3. Stephens R, Randolph DA, Huang G, Holtzman MJ, Chaplin DD. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J Immunol 2002;169:5458-67.
4. Corry DB, Folkesson HG, L. WM, Erie DJ, Matthay MA, Wiener-Kronish JP, et al. Interleukin 4, but not interlcukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1995;183:109-17.
5. Melhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A 1997;94:1344-9.
6. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-61.
7. Holtzman MJ, Sampath D, Castro M, Look DC, Jayaraman S. The one-two of T helper ceils: does interferon-γ knockout the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol 1996;14:316-8.
8. Hakonarson H, Bjornsdottir US, Ostermann E, Arnason T, Adalsteinsdottir AE, Halapi E, et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med 2001;164:2036-44.
9. Grayson MH, Holtzman MJ. Lessons from allergic rhinitis versus asthma pathogenesis and treatment. Immunol Allergy Clin N Am 2002;22:845-69.
10. Holtzman MJ, Morton JD, Shornick LP, Tyner JW, O'Sullivan MP, Antao A, et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev 2002;82:19-46.
11. Walter MJ, Look DC, Tidwell RM, Roswit WT, Holtzman MJ. Targeted inhibition of interferon-γ-dependent ICAM-I expression using dominant-negative Stat1. J Biol Chem 1997;272:28582-9.
12. Look DC, Roswit WT, Frick AG, Gris-Alevy Y, Dickhaus DM, Walter MJ. et al. Direct suppression of Stat1 function during adenoviral infection. Immunity 1998;9:871-80.
13. Koga T, Sardina E, Tidwell RM, Pelletier MR, Look DC, Holtzman MJ. Virus-inducible expression of a host chemokine gene relics on replication-linked mRNA stabilization. Proc Natl Acad Sci U S A 1999;96:5680-5.
14. Taguchi M, Sampath D, Koga T, Castro M, Look DC, Nakajima S, et al. Patterns for RANTES secretion and intercellular adhesion molecule-1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J Exp Med 1998;187:1927-40.
15. Sampath D, Castro M, Look DC, Holtzman MJ. Constitutive activation of an epithelial signal transducer and activator of transcription (Stat1) pathway in asthma. J Clin Invest 1999;103:1353-61.
16. Walter MJ, Kajiwara N, Karanja P, Castro M, Holtzman MJ. IL-12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001;193:339-52.
17. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 2002;110:165-75.
18. Shen Y, Zhu H, Shenk T. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate "hit and run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A 1997;94:3341-5.
19. Coyle AJ, Tsuyuki S, Bertrand C, Huang S, Aguet M, Alkan SS, et al. Mice lacking the IFN-γ receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol 1996;156:2680-5.
20. + T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 2001;166:1813-22.
21. + T cells that persist in the lungs. J Exp Med 2001;193:981-6.
22. + cells can switch to interlcukin 5 production and induce airway eosinophilla. J Exp Med 1995;181:1229-33.
23. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophila during experimental murine respiratory syncytial virus infection. J Exp Med 1997;186:421-32.
24. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999;162:4207-11.
25. Ashwell JD, Lu FWM, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000;18:309-45.